Analyst Ratings For NASDAQ:TVTY – Tivity Health (NASDAQ:TVTY)
Today, NASDAQ:TVTY – Tivity Health (NASDAQ:TVTY) stock received an upgrade by Chardan Capital from Neutral ➝ Buy with a price target of $42.00.
Some recent analyst ratings include
- 6/4/2018-Chardan Capital Upgrade from a “Neutral ➝ Buy” rating to a “” rating.
- 4/24/2018-Piper Jaffray Companies Reiterated Rating of Buy.
- 4/23/2018-Cantor Fitzgerald Reiterated Rating of Buy.
- 9/25/2017-Jefferies Group Reiterated Rating of Buy.
- On 5/1/2018 Donato Tramuto, CEO, sold 20,000 with an average share price of $35.37 per share and the total transaction amounting to $707,400.00.
- On 4/2/2018 Donato Tramuto, CEO, sold 20,000 with an average share price of $39.30 per share and the total transaction amounting to $786,000.00.
- On 3/1/2018 Donato Tramuto, CEO, sold 20,000 with an average share price of $38.53 per share and the total transaction amounting to $770,600.00.
- On 11/21/2017 Conan Laughlin, Director, sold 140,000 with an average share price of $34.90 per share and the total transaction amounting to $4,886,000.00.
- On 11/17/2017 Conan Laughlin, Director, sold 490,000 with an average share price of $34.34 per share and the total transaction amounting to $16,826,600.00.
- On 11/15/2017 Conan Laughlin, Director, sold 115,087 with an average share price of $33.87 per share and the total transaction amounting to $3,897,996.69.
- On 11/6/2017 Conan Laughlin, Director, sold 120,000 with an average share price of $47.52 per share and the total transaction amounting to $5,702,400.00.
Recent Trading Activity for NASDAQ:TVTY – Tivity Health (NASDAQ:TVTY)
Shares of NASDAQ:TVTY – Tivity Health closed the previous trading session at 34.58 up +0.67 1.99% with 35.0 shares trading hands.